The prevalence of asthma is increasing worldwide. In most patients, asthma can be controlled satisfactorily using a combination of anti-inflammatory drugs, including inhaled corticosteroids and bronchodilators 1 . However, even after treatment with maximum combination therapy, some patients continue to exhibit symptoms despite good compliance with medications and good inhalation technique. Such dif cult-to-control or refractory asthma accounts for approximately 5% of all cases 2 , but the exact prevalence of refractory asthma remains unknown because of the lack of a standardized de nition.
Risk factors for asthma exacerbation symptoms, or the rescue use of oral corticosteroids in the 12 months prior to the study.
Lung function
Forced expiratory volume in 1 second FEV 1.0 and vital capacity VC were measured after patients had taken their regular medications in the morning and are expressed as a percentage of predicted values.
Potential contributing factors
Thirteen factors proposed by ten Brinke et al 4 that possibly contribute to frequent asthma exacerbation were evaluated in the present study, namely ongoing allergen exposure, food allergen, drug allergy, occupational sensitizers, severe chronic sinus diseases, gastroesophageal re ux disease GERD , recurrent respiratory infections, relative immune de ciency, hyperthyroidism, sleep apnea syndrome SAS , hormonal effects, psychological dysfunction, and poor inhaler technique. Ongoing allergen exposure was diagnosed with allergen-speci c
immunoglobulin Ig E against house dust mite and pets. Patients were asked about the effects of food allergens on asthma, and food-speci c IgE was measured. Patients were also asked about allergies to drugs, including nonsteroidal anti-inflammatory drugs NSAIDs .
Occupational sensitizers were included in the analysis. The presence of severe chronic sinus disease was investigated by independent otorhinolaryngologists using CT scans. The presence of GERD was diagnosed on the basis of 24-h pH measurements of the esophagus or as an improvement of symptoms after treatment with proton pump inhibitors. Recurrent respiratory infections were de ned as two or more of symptoms involving the nose or throat, cough, and systemic features, as well as the use of antibiotics more than three times during the previous year. Relative immune de ciency was determined by measurement of IgG, IgA, and IgM levels. Hyperthyroidism was diagnosed on the basis of both clinical symptoms and plasma levels of free thyroxine. Polysomnography was performed to assess the presence of SAS. Hormonal effects were assessed by asking patients about asthma symptoms wheezing, hypoxia, hypersecretion of sputum, persistent cough, etc. during menstruation, pregnancy, or at menopause. Possible psychological dysfunction was de ned by a score of 6 or more on the General Health Questionnaire 12 4 . Aspirin intolerance was de ned as the presence of a typical clinical event including bronchial bronchospasm, tightness of chest, wheezing and/ or extrabronchial rhinorrhea, nasal congestion, ocular congestion, periorbital swelling, erythema of the skin symptoms, occurring between 15 min and 3 h after ingestion of aspirin or NSAIDs. Finally, inhalation technique was evaluated by asthma specialists. Patients who were being treated for these confounding diseases were also enrolled in the present study.
Statistical analysis
Differences between groups were investigated using unpaired t-test or the Mann-Whitney test, depending on whether the data were distributed normally or not. Odds ratios ORs were obtained by multiple logistic regression analysis after adjusting for age. Data are expressed as the mean standard error of the mean SEM , and P 0.05 was taken to indicate signi cance.
Results

Patient characteristics
The frequency of ATS severity criteria in the two groups is given in Table 1 . Despite treatment with high doses of inhaled corticosteroids, 28.6% of patients with refractory asthma required oral corticosteroids for more than 50% of the previous year. Although nearly all patients with refractory asthma were using a second controller medication, more than half had frequent exacerbations that required treatment with oral corticosteroids during the previous year. Moreover, a near-fatal event had occurred in the past year in 12.7% of patients with refractory asthma. Patients with well-controlled asthma were treated with lowto-moderate doses of inhaled corticosteroids, and 69.2% of these patients used a second controller medication. However, only 6.2% of patients had asthma exacerbation and none had had a near-fatal event in the previous year.
Detailed patient characteristics for the well-controlled and refractory asthma groups are given in Table 2 . There were no signi cant differences in age, percentage of female patients, history of asthma in childhood, body mass index BMI , peripheral eosinophil count, or smoking history between the two groups. However, the duration of asthma was longer in patients with refractory asthma than in patients with well-controlled asthma. In addition, the dose of inhaled corticosteroids, the rate of use of oral corticosteroids, and the rate of combined use of long-acting 2 -adrenoceptor agonists and leukotriene receptor antagonists with inhaled corticosteroids were signi cantly higher in patients with refractory asthma compared with patients with well-controlled asthma. The percent predicted FEV 1.0 was signi cantly lower in patients with refractory asthma compared with patients with well-controlled asthma.
Moreover, the rate of acute asthma exacerbation during the previous year was signi cantly higher in patients with refractory asthma compared with patients with well-controlled asthma 88.9% vs 21.1%, respectively .
Prevalence of potential comorbid factors
The prevalence of potential comorbid factors was assessed using systematic protocols. The prevalence of comorbid factors in both groups is given in Table 3 . Aspirin intolerance and atopic dermatitis were signi cantly more prevalent in patients with refractory asthma. In addition, the prevalence of recurrent respiratory infections, hormonal effects in women, and psychological dysfunction was signi cantly greater in patients with refractory asthma compared with patients with well-controlled asthma. 
Factors associated with frequent asthma exacerbation
Patients with refractory asthma were analyzed to identify risk factors for frequent asthma exacerbation. Table 4 
Discussion
In the present study we evaluated Japanese patients with refractory asthma using a systematic protocol and obtained a clinical pro le of patients with frequent asthma exacerbation. The prevalence of aspirin intolerance, psychological dysfunction, recurrent respiratory infections, and hormonal effects was signi cantly greater in patients with refractory asthma than in patients with well-controlled asthma. Factors signi cantly associated with frequent asthma exacerbation during the previous year in patients with refractory asthma were psychological dysfunction, aspirin intolerance, GERD, and recurrent respiratory infection.
The prevalence of aspirin intolerance in the healthy population is 0.3% 0.6% 6 . In adults with asthma, the incidence is much higher, ranging from 3% to 21% depending on the diagnostic methods used 7 . When aspirin challenge is combined with spirometry, the rate of aspirin intolerance in adults with asthma ranges between 8% and 20%, whereas surveys relying on history alone nd a lower rate, usually approximately 5% 8 11 . Aspirin intolerance has been reported to be associated with more severe asthma in Australian patients with asthma 12 . In addition, a questionnaire survey in Japan has found that aspirinintolerant asthma contributes to near-fatal asthma events 13 . More recently, aspirin sensitivity has been found to be associated with increased asthma severity and possible remodeling of both the upper and lower airways 14 . In the present study we found that the prevalence of is not a signi cant factor associated with the frequency of asthma exacerbation 4 , in the present study we found a strong association between aspirin intolerance and the frequency of asthma exacerbation in patients with refractory asthma, a nding also obtained by the European Network for Understanding Mechanisms of Severe Asthma ENFUMOSA study 15 . Therefore, aspirin intolerance may be closely associated with refractory asthma in Japanese patients.
Several psychosocial and emotional factors have been linked to poor asthma control, nearfatal asthma events, and asthma mortality. ten Brinke et al have reported that psychological dysfunction increases the ORs for frequent visits to general practioners, frequent emergency room visits, frequent exacerbation, and frequent hospitalization 16 . Similar results were obtained in the present study, namely that psychological dysfunction, as identi ed using the General Health Questionnaire, was associated with frequent exacerbation in patients with refractory asthma.
Recent studies have found that respiratory infection contributes to acute exacerbation of asthma and chronic persistent asthma 17 . Yamada et al have reported that latent adenoviral infection results in corticosteroid resistance in guinea pigs 18 . Moreover, viral infection induces airway in ammation and hyperresponsiveness 19 . In the present study, we did not nd a signi cant difference in relative immune de ciency between patients with refractory asthma and those with well-controlled asthma; however, recurrent respiratory infection was identi ed as a risk factor for frequent exacerbation in patients with refractory asthma. The odds ratios OR were adjusted for age. CI, con dence interval.
The relationship between GERD and asthma is particularly notable in patients with difcult-to-treat asthma 20 . The reported prevalence of GERD in East Asia ranges from 2.5% to 6.7% 21 , and is lower than that in other areas. In the present study, the prevalence of GERD did not differ signi cantly between patients with refractory asthma and those with well-controlled asthma 17.5% vs 7.7%, respectively , but GERD was identi ed as an important risk factor for exacerbation in patients with refractory asthma. These results suggest that GERD may affect the control of asthma and increase the frequency of exacerbation in combination with other risk factors.
Severe asthma is two-to three-fold more common in women than in men, as shown by the ENFUMOSA 15 and the Outcomes and Treatment Regimens TENOR 14 studies.
Although asthma may be related to menstruation in a small percentage of women with asthma, these patients often have severe asthma 22 . This increased severity is probably the result of endocrine factors, because a strong correlation has been reported between severe asthma and the menstrual cycle 23 . Moreover, some studies suggest that there is a decline in pulmonary function as estrogen levels decrease during the premenstrual phase 24, 25 .
Dimitropoulou et al reported cellular mechanisms of estrogen that reduce constriction of asthmatic airways in murine models 26 . In addition, the few small studies that have been performed suggest an increase in in ammation before menstruation in susceptible women 27 .
In the present study, asthma was related to hormonal changes in 28.6% of women with refractory asthma, and hormonal changes may be a cause of asthma exacerbation in some women with refractory asthma. Sinusitis is extremely common in patients with severe asthma, and the severity of sinusitis has been linked to both in ammation and abnormalities in lung function 28 . Moreover, a large cohort study has demonstrated that more than 70% of patients with asthma report either allergic rhinitis or sinusitis 29 . However, the present study failed to show any signicant association between asthma exacerbation and either allergic rhinitis or sinusitis. Possible reasons for this difference are that the present study had a small number of patients and that 23.8% of patients with refractory asthma had already been treated for these diseases.
A recent large-scale epidemiologic study of patients with severe/difficult-to-treat asthma TENOR has suggested that there is a positive correlation between BMI and disease severity 30 . Many obese patients may have SAS, which can affect overall lung function. In Despite our efforts to investigate the comorbid conditions using a systematic protocol, there are several limitations to the present study. First, we did not investigate the phenotype of airway in ammation and other mechanisms to explain why asthma was dif cult to treat in patients with refractory asthma. Second, the pathophysiological interactions between Risk factors for asthma exacerbation comorbid factors and refractory asthma were not investigated in detail. Third, the effects of intensive treatment of comorbid factors on asthma exacerbation were not studied in patients with refractory asthma. Therefore, the effects of treatment of both the refractory asthma itself and the comorbid conditions on asthma control must be evaluated in a long-term prospective study.
The present study has evaluated Japanese patients with refractory asthma according to a systematic protocol and obtained a clinical pro le of patients with frequent asthma exacerbation. Rigorous treatment of comorbid factors, such as aspirin intolerance, psychological dysfunction, GERD, and recurrent respiratory infection, may improve the management of refractory asthma in Japanese patients.
